CSBR — Champions Oncology Inc

Champions Oncology Inc (CSBR) is a biotechnology company listed on NASDAQ. It is led by Ronnie Morris M.D., based in One University Plaza, Hackensack, NJ, United States, 07601, with about 210 employees. Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Latest reported CSBR revenue for 2025-07-31 was $14.0M. Net income was -$436.0K. Revenue was up 0.0% from 2025-07-31 to 2025-07-31. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.

Use this CSBR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CSBR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CSBR SEC filings page. Lician reads the product cache first so this HTML stays unique to Champions Oncology Inc even when a live quote feed is slow.